Cannabinoids to treat spinal cord injury-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cannabinoids to treat spinal cord injury

Published:2016-01 Issue: Volume:64 Page:190-199
ISSN:0278-5846
Container-title:Progress in Neuro-Psychopharmacology and Biological Psychiatry
language:en
Short-container-title:Progress in Neuro-Psychopharmacology and Biological Psychiatry

Author:

Arevalo-Martin Angel,Molina-Holgado Eduardo,Garcia-Ovejero Daniel

Funder

Instituto de Salud Carlos III

Wings for Life Foundation

Fundacion Mutua Madrileña

Publisher

Elsevier BV

Subject

Biological Psychiatry,Pharmacology

Reference157 articles.

1. The gastrointestinal pharmacology of cannabinoids: focus on motility;Abalo;Pharmacology,2012

2. Modulation of inflammatory responses by a cannabinoid-2-selective agonist after spinal cord injury;Adhikary;J Neurotrauma,2011

3. Therapeutic action of cannabinoids in a murine model of multiple sclerosis;Arevalo-Martin;J Neurosci,2003

4. Cannabinoids modulate Olig2 and polysialylated neural cell adhesion molecule expression in the subventricular zone of post-natal rats through cannabinoid receptor 1 and cannabinoid receptor 2;Arevalo-Martin;Eur J Neurosci,2007

5. The endocannabinoid 2-arachidonoylglycerol reduces lesion expansion and white matter damage after spinal cord injury;Arevalo-Martin;Neurobiol Dis,2010

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combined non-psychoactive Cannabis components cannabidiol and β-caryophyllene reduce chronic pain via CB1 interaction in a rat spinal cord injury model;PLOS ONE;2023-03-13

2. Cannabinoid Use for Pain Reduction in Spinal Cord Injuries: A Meta-Analysis of Randomized Controlled Trials;Frontiers in Pharmacology;2022-04-28

3. Endocannabinoid signaling in oligodendroglia;Glia;2022-04-12

4. On the therapeutic targets and pharmacological treatments for pain relief following spinal cord injury: A mechanistic review;Biomedicine & Pharmacotherapy;2021-07

5. Targeting the CB 2 receptor and other endocannabinoid elements to delay disease progression in amyotrophic lateral sclerosis;British Journal of Pharmacology;2021-02-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3